ADVANZ by Opceden Liveryll Tablet
ADVANZ by Opceden Liveryll Tablet : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL22056071TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- ASIA HEALTHCARE SDN. BHD.
- Manufacturer
- YANLING NATURAL HYGIENE SDN. BHD.
- Registration date
- 2022-05-23
- Published validity end
- 2027-05-23
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Silybum marianum | Silybum marianum[200.00 mg,1000.00 mg] | Not identified |
| Phyllanthus niruri | Phyllanthus niruri[200.00 mg,1000.00 mg] | Not identified |
| Taraxacum mongolicum | Taraxacum mongolicum[100.00 mg,1000.00 mg] | Not identified |
| Glycyrrhiza uralensis | Glycyrrhiza uralensis[50.00 mg,1000.00 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Silybum marianum[200.00 mg,1000.00 mg],Phyllanthus niruri[200.00 mg,1000.00 mg],Taraxacum mongolicum[100.00 mg,1000.00 mg],Glycyrrhiza uralensis[50.00 mg,1000.00 mg]
- Valid until
- 2027-05-23
- Registration date
- 2022-05-23
- Published description
- NATURAL PRODUCT
- Licence holder
- ASIA HEALTHCARE SDN. BHD.
- Producer
- YANLING NATURAL HYGIENE SDN. BHD.
- Published name
- ADVANZ by Opceden Liveryll Tablet
- Published reference
- 202202246995T
- Registration number
- MAL22056071TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL22056071TC
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.